查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886172

數位生物製造市場規模、佔有率、預測及趨勢分析：按產品（軟體/硬體）、功能（產品設計、分析、自動化）、應用（單株抗體、蛋白質、疫苗）和生物製程劃分－全球預測至2035年

Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software Hardware), Functionality (Product Design, Analytics, Automation), Applicatison (MAB, Protein, Vaccine), and Bioprocess - Global Forecast to 2035
出版日期: | 出版商: Meticulous Research | 英文 226 Pages | 訂單完成後即時交付

價格

預計2025年至2035年，數位生物製造市場將以12.6%的複合年增長率成長，到2035年達到764億美元。本報告對五大主要地區的數位生物製造市場進行了詳細分析，重點關注當前市場趨勢、市場規模、近期發展以及至2035年的預測。

基於廣泛的二級和一級研究以及對市場現狀的詳細分析，本報告對關鍵行業驅動因素、限制因素、機會和挑戰的影響進行了分析。此市場成長的驅動因素包括：對生物製藥的需求不斷增長、大型企業擴大生物製藥廠產能、對連續生物製程的日益重視、生物製造製程優化需求的不斷增長，以及對品質標準和法規遵從性的日益重視。此外，人工智慧 (AI) 和機器學習的融合、基於雲端的製造平台、數位孿生技術的應用以及向生物工藝 4.0 的轉型，預計也將支持市場成長。

然而，仍有許多挑戰，包括技術採用成本高昂、生物製藥的研發和生產流程複雜、與傳統系統整合方面的挑戰，以及對資料安全和智慧財產權保護的擔憂。

數位生物製造市場按產品（軟體和硬體）、功能（產品設計、流程優化和分析、自動化和控制、即時品質監控和合規性、供應鍊和營運管理以及其他功能）、生物製程（上游和下游生物製程）、應用（單株抗體、重組荷爾蒙/蛋白、疫苗、細胞生物製劑、基因生物製劑、生物相似藥、工業生物技術以及其他應用）、最終用戶（生物製藥公司、學術和研究機構、CDMO/CRO、食品和工業生物技術公司以及其他最終用戶）和地區進行細分。本研究也評估了產業競爭對手，並提供了國家層面的市場分析。

預計到 2025 年，軟體領域將佔最大的市場佔有率，達到 58%。該領域的主導地位主要歸功於其作為核心智慧層的基礎性作用，它驅動著所有生物製造流程的流程優化、數據分析和即時決策。這些軟體包括先進的製程分析技術 (PAT) 系統、先進的數據分析軟體、製造執行系統 (MES) 以及能夠創建生物製程操作虛擬副本的尖端數位孿生平台。此外，嵌入這些平台的人工智慧 (AI) 和機器學習功能的持續發展也推動了該領域的成長。我們看到，簡單的監控系統正在轉變為能夠進行預測分析、自主流程調整和認知決策的智慧平台。在預測期內，受雲端解決方案和高階分析技術日益普及的推動，軟體領域也預計將顯著成長。

預計到2025年，製程優化和分析領域將引領數位生物製造市場。該領域的領先地位反映了生物製造製程持續改進的重要性，即使是微小的最佳化也能顯著降低成本、提高產量和品質。製程優化和分析包括先進的統計製程控制、實驗設計 (DoE)、多元數據分析以及基於機器學習的最佳化演算法，這些技術能夠持續分析製程參數並識別改進機會。這些系統整合了來自整個生物製程工作流程中多個來源的數據，從而提供對製程性能的全面洞察。這使製造商能夠在確保合規性的同時，實現更高的產品產量、降低批次間差異並最大限度地降低生產成本。然而，在預測期內，供應鏈營運管理預計將以16.5%的複合年增長率（CAGR）實現最高成長，這主要得益於全球生物製藥企業日益認識到端到端可視性和協調的重要性。

預計到2025年，上游生物製程將佔數位生物製造市場最大的佔有率。這一主導地位源於其作為所有生物製造營運基礎的根本作用，以及其對整體工藝經濟性的顯著影響。上游製程的最佳化尤其重要，因為它們直接影響產品的產量、品質和一致性。細胞培養製程的複雜性，包括pH值、溶解氧、溫度、營養水平和代謝物濃度等眾多相互依存的變量，為數位化優化創造了巨大的機會。先進的製程分析技術、即時監控系統和人工智慧驅動的控制演算法能夠顯著提高細胞生產力、降低污染風險並優化培養基消耗，從而促進數位化解決方案在上游生物製程的廣泛應用。

預計2025年，單株抗體領域將佔數位生物製造市場最大的佔有率，達到33%。該領域佔有率佔比高主要歸功於其完善的生產基礎設施、成熟的生產流程以及產品本身巨大的商業價值。單株抗體複雜的多步驟生產流程（包括細胞系開發、上游細胞培養、下游純化、製劑配製以及灌裝包裝等製程）為數位化優化提供了許多機會。單株抗體的高價值和大規模生產特性，促使企業對先進的數位技術進行大量投資，以提高產量、降低生產成本並確保產品品質的穩定性。然而，基因工程生物製劑領域預計將實現最快成長，在預測期內複合年增長率將達到17.9%。隨著這些新興療法獲得監管部門批准並取得商業成功，FDA預計到2025年每年將批准10至20種細胞和基因治療產品。

預計到2025年，生物製藥公司將佔數位生物製造市場最大的佔有率。對生物製藥日益增長的偏好、個人化醫療研究的不斷深入以及支持生物製藥應用的政策，正在推動該領域佔最大的市場佔有率。由於生物製藥通常較為複雜，且生產成本高於傳統藥物，生物製造業正擴大採用數位化解決方案來減少錯誤並擴大生產規模。生物製藥公司數量的不斷增長及其對數位技術的逐步採用，推動了該領域的領先地位，約55%的公司已在其工作流程中實施了數位技術。

本產業區域分析提供了對五大主要區域（北美、歐洲、亞太、拉丁美洲以及中東和非洲）及其各區域內主要國家的詳細定性和定量見解。

預計到2025年，北美將佔數位生物製造市場最大的佔有率（38%）。該地區佔有率龐大，得益於其擁有眾多大型生物製藥公司、先進的技術基礎設施、大量的研發投資以及有利的監管環境。特別是美國，擁有眾多生物技術中心，並在生物製劑的開發和生產方面保持領先地位。北美成熟的生物製藥生態系統匯聚了許多擁有廣泛生產網路、高度發展的供應鏈以及充足技術實施資金的大型公司。該地區的監管框架，以美國食品藥物管理局 (FDA) 為首，一直積極推動先進製造技術的應用，並為生物製造領域的數位化技術提供指導。

然而，預計亞太地區在預測期內將實現最高的數位化生物製造市場複合年增長率 (CAGR)，達到 16.0%。這一成長主要得益於中國、印度、日本和韓國等國家生物製藥產業的快速發展。該地區的成長動力來自政府對生物技術領域投資的增加、國內對生物製藥需求的增長、生產能力的提升以及高性價比的合約研發生產機構 (CDMO) 的存在。此外，政府加大數位投入、對高性價比自動化解決方案的需求不斷增長、生物製藥生產基礎設施的擴建以及人口稠密國家對營運效率的日益重視，都在推動市場擴張。該地區蓬勃發展的生物技術產業、不斷擴大的研發活動、日益增長的熟練勞動力、生命科學領域不斷增加的外國直接投資，以及支持數位技術的監管框架，正在為市場成長創造有利環境。

研究範圍

按產品/服務劃分的數位生物製造市場評估

  • 軟體
    • 過程分析技術
    • 數據分析軟體
    • 製造執行系統
    • 數位孿生平台
  • 硬體
  • 服務

按功能劃分的數位生物製造市場評估

  • 產品設計
  • 過程最佳化與分析
  • 自動化與控制
  • 即時品質監控與合規性
  • 供應鏈與營運管理
  • 其他功能

按生物製程劃分的數位生物製造市場評估

  • 上游生物工藝
  • 下游生物製程生物加工

數位生物製造市場評估：按應用領域劃分

  • 單株抗體
  • 重組荷爾蒙/蛋白質
  • 疫苗
  • 細胞生物製品
  • 基因生物製品
  • 生物相似藥
  • 工業生物技術
  • 其他應用

數位生物製造市場評估：按最終用戶劃分

  • 生物製藥公司
  • 學術和研究機構
  • 合約研發生產力機構 (CDMO) 和合約研究組織 (CRO)
  • 食品和工業生物技術公司
  • 其他最終用戶

數位生物製造市場評估：按地區劃分

  • 北美
    • 美國美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞士
    • 丹麥
    • 愛爾蘭
    • 比利時
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲國家

表格內容

第一章：引言

第二章：研究方法

第三章：摘要整理

  • 細分市場分析
    • 依產品類型劃分的市場分析
    • 依功能劃分的市場分析
    • 依生物製程劃分的市場分析
    • 按應用劃分的市場分析
    • 依最終用戶劃分的市場分析
  • 地理分析
  • 競爭分析

第四章 市場洞察

  • 影響市場成長的因素
    • 驅動因素
      • 生物製藥需求不斷成長
      • 主要公司擴大生物製藥廠產能
      • 對製程優化的需求不斷成長
      • 對質量標準及法規遵守的關注度不斷提高
      • 強大的生物製藥研發管線
      • 日益重視連續生物工藝
    • 限制因素
      • 高昂的技術實施成本
      • 複雜的生物製藥開發與生產工藝
    • 機遇
      • 工業4.0機遇
      • 先進資料分析工具的可用性
      • 向生物製程4.0轉型
    • 挑戰
      • 過程分析技術 (PAT) 實施的複雜性
    • 趨勢
      • 人工智慧 (AI) 和機器學習的集成
      • 基於雲端的製造平台
      • 先進的製程控制與自動化

第五章 數位化生物製造市場依產品/服務分類評估

  • 軟體
    • 過程分析技術 (PAT)
    • 數據分析軟體
    • 製造執行系統 (MES)
    • 數位孿生平台
  • 硬體
  • 服務

第六章：數位生物製造市場依功能分類評估

  • 產品設計
  • 過程最佳化與分析
  • 自動化與控制
  • 即時品質監控與合規
  • 供應鏈與營運管理
  • 其他（預測性維護、永續性儀表板）

第七章：數位生物製造市場依生物製程分類評估

  • 上游生物工藝
  • 下游生物製程生物加工

第八章：按最終用戶劃分的數位化生物製造市場評估

  • 單株抗體 (MAbs)
  • 重組荷爾蒙/蛋白質
  • 疫苗
  • 細胞生物製品
  • 基因生物製品
  • 生物相似藥
  • 工業生物技術（酵素、生物基化學品、食品和飼料原料）
  • 其他（血液製品、勝肽和寡核苷酸）

第九章：按最終用戶劃分的數位化生物製造市場評估

  • 生物製藥公司
  • 學術和研究機構
  • 合約研發生產力機構 (CDMO) 和合約研究組織 (CRO)
  • 食品和工業生物技術公司
  • 其他（政府實驗室、聯盟和非營利組織）

第十章：數位生物製造市場評估：按地區劃分

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 瑞士
    • 丹麥
    • 愛爾蘭
    • 比利時
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 亞太其他地區
  • 拉丁美洲美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區 (RoLATAM)
  • 中東和非洲

第11章 競爭格局

  • 關鍵成長策略
  • 競爭標竿分析
  • 競爭概覽
    • 行業領導者
    • 市場差異化因素
    • 產業先鋒
    • 新興企業
  • 市佔率/市場地位分析

第12章 公司簡介

  • GE醫療科技公司
  • 西門子Xcelerator
  • Cytiva
  • ABB有限公司
  • 賽諾菲公司
  • 艾默生電氣公司
  • 霍尼韋爾國際公司
  • SAP SE
  • Ovo Biomanufacturing Ltd.
  • 施耐德電機公司
  • 達梭系統公司
  • 甲骨文公司
  • 3M公司

第十三章：附錄

Product Code: MRHC - 1041288

Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software [PAT, MES, Digital Twin] Hardware), Functionality (Product Design, Analytics, Automation), Application (MAB, Protein, Vaccine), and Bioprocess - Global Forecast to 2035

According to the research report titled, 'Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software [PAT, MES, Digital Twin], Hardware), Functionality (Product Design, Analytics, Automation), Application (MAB, Protein, Vaccine), and Bioprocess-Global Forecast to 2035,' the digital biomanufacturing market is projected to reach $76.4 billion by 2035, at a CAGR of 12.6% during the forecast period 2025-2035. The report provides an in-depth analysis of the global digital biomanufacturing market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.

Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the escalating demand for biologics, capacity expansions of biopharmaceutical plants by key players, increased focus on continuous bioprocessing, rising need for process optimization in biomanufacturing, and the growing emphasis on quality standards and regulatory compliance. Moreover, the integration of artificial intelligence and machine learning, cloud-based manufacturing platforms, digital twin technology adoption, and the shift towards Bioprocessing 4.0 are expected to support the market's growth.

However, the market's growth faces notable challenges including the high cost of technology deployment, complex development and manufacturing processes of biopharmaceuticals, integration challenges with legacy systems, and concerns about data security and intellectual property protection.

The key players operating in the digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (subsidiary of Siemens) (Germany), Cytiva (subsidiary of Danaher Corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric Co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing Inc. (U.S.), Schneider Electric SE (France), Dassault Systemes (France), Oracle Corporation (U.S.), and 3M (U.S.).

The digital biomanufacturing market is segmented by offering (software and hardware), functionality (product design, process optimization & analytics, automation & control, real-time quality monitoring and compliance, supply chain and operations management, and other functionalities), bioprocess (upstream bioprocess and downstream bioprocess), application (monoclonal antibodies, recombinant hormones/proteins, vaccines, cellular-based biologics, gene-based biologics, biosimilars, industrial biotech, and other applications), end user (biopharmaceutical companies, academic and research institutes, CDMOs & CROs, food and industrial biotech companies, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

The software segment is projected to account for the largest market share of 58% in 2025. The dominance of this segment is primarily attributed to its fundamental role as the core intelligence layer driving process optimization, data analytics, and real-time decision-making across all biomanufacturing processes. This includes sophisticated process analytical technology (PAT) systems, advanced data analysis software, manufacturing execution systems (MES), and cutting-edge digital twin platforms that create virtual replicas of bioprocessing operations. The segment's growth is further accelerated by the continuous evolution of artificial intelligence and machine learning capabilities embedded within these platforms, transitioning from simple monitoring systems to intelligent platforms capable of predictive analytics, autonomous process adjustments, and cognitive decision-making. The software segment is also expected to register significant growth during the forecast period, driven by increasing adoption of cloud-based solutions and advanced analytics capabilities.

The process optimization & analytics segment is expected to dominate the digital biomanufacturing market in 2025. This segment's leadership reflects the critical need for continuous improvement in biomanufacturing processes, where even minor optimizations can result in significant cost savings, yield improvements, and quality enhancements. Process optimization & analytics encompasses advanced statistical process control, design of experiments (DoE), multivariate data analysis, and machine learning-powered optimization algorithms that continuously analyze process parameters to identify opportunities for improvement. These systems integrate data from multiple sources across the bioprocessing workflow to provide comprehensive insights into process performance, enabling manufacturers to achieve higher product yields, reduce batch-to-batch variability, and minimize production costs while maintaining regulatory compliance. However, the supply chain & operations management segment is projected to register the highest CAGR of 16.5% during the forecast period, driven by the increasing recognition of the importance of end-to-end visibility and coordination across global biopharmaceutical operations.

The upstream bioprocess segment is expected to account for the largest share of the digital biomanufacturing market in 2025. The upstream segment's dominance is due to its fundamental role as the foundation of all biomanufacturing operations and its significant impact on overall process economics. Upstream processes directly influence product yield, quality, and consistency, making optimization in this area particularly valuable. The complexity of cell culture processes, with their numerous interdependent variables including pH, dissolved oxygen, temperature, nutrient levels, and metabolite concentrations, creates substantial opportunities for digital optimization. Advanced process analytical technology, real-time monitoring systems, and AI-powered control algorithms can significantly improve cell productivity, reduce contamination risks, and optimize media consumption, driving the widespread adoption of digital solutions in upstream bioprocessing.

The monoclonal antibodies segment is expected to account for the largest share of 33% of the digital biomanufacturing market in 2025. The large share of this segment is attributed to the established manufacturing infrastructure, well-understood production processes, and significant commercial value of these products. The complex multi-step production process of monoclonal antibodies, involving cell line development, upstream cell culture, downstream purification, formulation, and fill-finish operations, creates numerous opportunities for digital optimization. The high value and large production volumes of monoclonal antibodies justify substantial investments in advanced digital technologies that can improve yields, reduce production costs, and ensure consistent product quality. However, the gene-based biologics segment is experiencing the fastest growth at a CAGR of 17.9% during the forecast period, as this emerging therapeutic modality gains regulatory approval and commercial traction, with the FDA anticipating approval of 10 to 20 cell and gene therapy products per year by 2025.

The biopharmaceutical companies segment is expected to account for the largest share of the digital biomanufacturing market in 2025. The increasing preference for biopharmaceuticals, growing research in personalized medicines, and supportive initiatives for the adoption of biopharmaceuticals are supporting the segment's largest market share. Biopharmaceuticals are typically complex and costlier than conventional drugs to manufacture, leading biomanufacturing industries to deploy digital solutions to reduce errors and scale up production processes. The increasing number of biopharmaceutical companies along with the gradually increasing adoption of digital technologies in these companies contributes to the segment's dominance, with approximately 55% of companies having incorporated digital technologies in their workflows.

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region.

North America is expected to account for the largest share of 38% of the digital biomanufacturing market in 2025. The large share of this region is attributed to the presence of leading biopharmaceutical companies, advanced technological infrastructure, substantial R&D investments, and a supportive regulatory environment. The United States, in particular, hosts numerous biotechnology hubs and maintains a leadership position in biologics development and manufacturing. North America's established biopharmaceutical ecosystem includes major companies with extensive manufacturing networks, well-developed supply chains, and significant financial resources for technology adoption. The region's regulatory framework, led by the FDA, has been progressive in encouraging the adoption of advanced manufacturing technologies and providing guidance on digital technologies in biomanufacturing.

However, Asia-Pacific is projected to register the highest CAGR of 16.0% during the forecast period across the overall digital biomanufacturing market. This growth is fueled by the rapidly expanding biopharmaceutical sectors in countries such as China, India, Japan, and South Korea. The region's growth is driven by increasing government investments in biotechnology, growing domestic demand for biologics, expanding manufacturing capacity, and the presence of cost-effective contract development and manufacturing organizations (CDMOs). Rising government initiatives aimed at digitization, growing demand for cost-effective automation solutions, expanding biopharmaceutical manufacturing infrastructure, and increasing focus on operational efficiency in densely populated countries are driving market expansion. The region's booming biotechnology sector, expanding research and development activities, growing skilled workforce, increasing foreign direct investments in the life sciences sector, and supportive regulatory frameworks for digital technology adoption are creating a conducive environment for market growth.

Key Questions Answered in the Report

  • What is the current revenue generated by the digital biomanufacturing market globally?
  • At what rate is the global digital biomanufacturing demand projected to grow for the next 10 years?
  • What are the historical market sizes and growth rates of the global digital biomanufacturing market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of offering, functionality, bioprocess, application, and end user are expected to create major traction for the manufacturers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global digital biomanufacturing market?
  • Who are the major players in the global digital biomanufacturing market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the global digital biomanufacturing market? What are the impacts of these strategic developments on the market?

Scope of the Report

Digital Biomanufacturing Market Assessment-by Offering

  • Software
    • Process Analytical Technology
    • Data Analysis Software
    • Manufacturing Execution System
    • Digital Twin Platforms
  • Hardware
  • Services

Digital Biomanufacturing Market Assessment-by Functionality

  • Product Design
  • Process Optimization & Analytics
  • Automation & Control
  • Real-Time Quality Monitoring and Compliance
  • Supply Chain and Operations Management
  • Other Functionalities

Digital Biomanufacturing Market Assessment-by Bioprocess

  • Upstream Bioprocess
  • Downstream Bioprocess

Digital Biomanufacturing Market Assessment-by Application

  • Monoclonal Antibodies
  • Recombinant Hormones/Proteins
  • Vaccines
  • Cellular-based Biologics
  • Gene-based Biologics
  • Biosimilars
  • Industrial Biotech
  • Other Applications

Digital Biomanufacturing Market Assessment-by End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • CDMOs & CROs
  • Food and Industrial Biotech Companies
  • Other End Users

Digital Biomanufacturing Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
    • Denmark
    • Ireland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1 Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations

2 Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
    • 2.3.2. Bottom-Up Approach
    • 2.3.3. Top-Down Approach
    • 2.3.4. Growth forecast
  • 2.4. Assumptions for the Study

3 Executive Summary

  • 3.1. Overview
  • 3.2. Segmental Analysis
    • 3.2.1. Market Analysis, by Offering
    • 3.2.2. Market Analysis, by Functionality
    • 3.2.3. Market Analysis, by Bioprocess
    • 3.2.4. Market Analysis, by Application
    • 3.2.5. Market Analysis, by End-User
  • 3.3. Regional Analysis
  • 3.4. Competitive Analysis

4 Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Drivers
      • 4.2.1.1. Growing Demand for Biologics
      • 4.2.1.2. Capacity Expansions of Biopharmaceutical Plants by Key Players
      • 4.2.1.3. Increased Need for Process Optimization
      • 4.2.1.4. Increased Focus on Quality Standards & Regulatory Compliance
      • 4.2.1.5. Strong R&D Pipeline for Biopharmaceuticals
      • 4.2.1.6. Rising Focus on Continuous Bioprocessing
    • 4.2.2. Restraints
      • 4.2.2.1. High Cost of Technology Deployment
      • 4.2.2.2. Complex Development and Manufacturing Process of Biopharmaceuticals
    • 4.2.3. Opportunities
      • 4.2.3.1. Introduction of Industry 4.0
      • 4.2.3.2. Availability of Advanced Data Analysis Tools
      • 4.2.3.3. Shift Towards Bioprocessing 4.0
    • 4.2.4. Challenges
      • 4.2.4.1. Complexities In Process Analytical Technology (Pat) Implementation
    • 4.2.5. Trends
      • 4.2.5.1. Integration of Artificial Intelligence and Machine Learning
      • 4.2.5.2. Cloud-Based Manufacturing Platforms
      • 4.2.5.3. Advanced Process Control and Automation

5 Digital Biomanufacturing Market Assessment - by Offering

  • 5.1. Overview
  • 5.2. Software
    • 5.2.1. Process Analytical Technology (Pat)
    • 5.2.2. Data Analysis Software
    • 5.2.3. Manufacturing Execution System (Mes)
    • 5.2.4. Digital Twin Platforms
  • 5.3. Hardware
  • 5.4. Services

6 Digital Biomanufacturing Market Assessment - by Functionality

  • 6.1. Overview
  • 6.2. Product Design
  • 6.3. Process Optimization & Analytics
  • 6.4. Automation & Control
  • 6.5. Real-Time Quality Monitoring & Compliance
  • 6.6. Supply Chain & Operations Management
  • 6.7. Others (Predictive Maintenance, Sustainability Dashboards)

7 Digital Biomanufacturing Market Assessment - by Bioprocess

  • 7.1. Overview
  • 7.2. Upstream Bioprocessing
  • 7.3. Downstream Bioprocessing

8 Digital Biomanufacturing Market Assessment - by Application

  • 8.1. Overview
  • 8.2. Monoclonal Antibodies (Mabs)
  • 8.3. Recombinant Hormones/Proteins
  • 8.4. Vaccines
  • 8.5. Cellular-Based Biologics
  • 8.6. Gene-Based Biologics
  • 8.7. Biosimilars
  • 8.8. Industrial Biotech (Enzymes, Bio-Based Chemicals, Food & Feed Ingredients)
  • 8.9. Others (Blood Products, Peptides, Oligonucleotides)

9 Digital Biomanufacturing Market Assessment - by End-User

  • 9.1. Overview
  • 9.2. Biopharmaceutical Companies
  • 9.3. Academic and Research Institutes
  • 9.4. CDMOs & CROs
  • 9.5. Food & Industrial Biotech Companies
  • 9.6. Others (Government Labs, Consortia, and Non-Profit Organizations)

10 Digital Biomanufacturing Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Switzerland
    • 10.3.7. Denmark
    • 10.3.8. Ireland
    • 10.3.9. Belgium
    • 10.3.10. Rest of Europe (RoE)
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. India
    • 10.4.4. South Korea
    • 10.4.5. Australia
    • 10.4.6. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America (RoLATAM)
  • 10.6. Middle East & Africa

11 Competitive Landscape

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share/Position Analysis

12 Company Profiles

  • 12.1. GE Healthcare Technologies, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Business Description
    • 12.1.3. Financial Overview
    • 12.1.4. Product Portfolio
    • 12.1.5. SWOT Analysis
  • 12.2. Siemens Xcelerator
    • 12.2.1. Company Overview
    • 12.2.2. Business Description
    • 12.2.3. Financial Overview
    • 12.2.4. Product Portfolio
    • 12.2.5. SWOT Analysis
  • 12.3. Cytiva
    • 12.3.1. Company Overview
    • 12.3.2. Business Description
    • 12.3.3. Financial Overview
    • 12.3.4. Product Portfolio
    • 12.3.5. SWOT Analysis
  • 12.4. ABB Ltd.
    • 12.4.1. Company Overview
    • 12.4.2. Business Description
    • 12.4.3. Financial Overview
    • 12.4.4. Product Portfolio
    • 12.4.5. SWOT Analysis
  • 12.5. Sanofi S.A.
    • 12.5.1. Company Overview
    • 12.5.2. Business Description
    • 12.5.3. Financial Overview
    • 12.5.4. Product Portfolio
    • 12.5.5. SWOT Analysis
  • 12.6. Emerson Electric Co.
    • 12.6.1. Company Overview
    • 12.6.2. Business Description
    • 12.6.3. Financial Overview
    • 12.6.4. Product Portfolio
    • 12.6.5. SWOT Analysis
  • 12.7. Honeywell International, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Business Description
    • 12.7.3. Financial Overview
    • 12.7.4. Product Portfolio
    • 12.7.5. SWOT Analysis
  • 12.8. SAP SE
    • 12.8.1. Company Overview
    • 12.8.2. Business Description
    • 12.8.3. Financial Overview
    • 12.8.4. Product Portfolio
    • 12.8.5. SWOT Analysis
  • 12.9. Ovo Biomanufacturing Ltd.
    • 12.9.1. Company Overview
    • 12.9.2. Business Description
    • 12.9.3. Financial Overview
    • 12.9.4. Product Portfolio
    • 12.9.5. SWOT Analysis
  • 12.10. Schneider Electric SE
    • 12.10.1. Company Overview
    • 12.10.2. Business Description
    • 12.10.3. Financial Overview
    • 12.10.4. Product Portfolio
    • 12.10.5. SWOT Analysis
  • 12.11. Dassault Systemes
    • 12.11.1. Company Overview
    • 12.11.2. Business Description
    • 12.11.3. Financial Overview
    • 12.11.4. Product Portfolio
    • 12.11.5. SWOT Analysis
  • 12.12. Oracle Corporation
    • 12.12.1. Company Overview
    • 12.12.2. Business Description
    • 12.12.3. Financial Overview
    • 12.12.4. Product Portfolio
    • 12.12.5. SWOT Analysis
  • 12.13. 3M
    • 12.13.1. Company Overview
    • 12.13.2. Business Description
    • 12.13.3. Financial Overview
    • 12.13.4. Product Portfolio
    • 12.13.5. SWOT Analysis

13 Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

  • Table 1 Global Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 2 Global Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 3 Global Digital Biomanufacturing Software Market, by Region/Country, 2023-2035 (USD Million)
  • Table 4 Global Process Analytical Technology (PAT) Market, by Region/Country, 2023-2035 (USD Million)
  • Table 5 Global Data Analysis Software Market, by Region/Country, 2023-2035 (USD Million)
  • Table 6 Global Manufacturing Execution System (MES) Market, by Region/Country, 2023-2035 (USD Million)
  • Table 7 Global Digital Twin Platforms Market, by Region/Country, 2023-2035 (USD Million)
  • Table 8 Global Digital Biomanufacturing Hardware Market, by Region/Country, 2023-2035 (USD Million)
  • Table 9 Global Digital Biomanufacturing Services Market, by Region/Country, 2023-2035 (USD Million)
  • Table 10 Global Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 11 Global Product Design Market, by Region/Country, 2023-2035 (USD Million)
  • Table 12 Global Process Optimization & Analytics Market, by Region/Country, 2023-2035 (USD Million)
  • Table 13 Global Automation & Control Market, by Region/Country, 2023-2035 (USD Million)
  • Table 14 Global Real-Time Quality Monitoring & Compliance Market, by Region/Country, 2023-2035 (USD Million)
  • Table 15 Global Supply Chain & Operations Management Market, by Region/Country, 2023-2035 (USD Million)
  • Table 16 Global Others (Predictive Maintenance, Sustainability Dashboards) Market, by Region/Country, 2023-2035 (USD Million)
  • Table 17 Global Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 18 Global Upstream Bioprocessing Market, by Region/Country, 2023-2035 (USD Million)
  • Table 19 Global Downstream Bioprocessing Market, by Region/Country, 2023-2035 (USD Million)
  • Table 20 Global Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 21 Global Digital Biomanufacturing Market for Monoclonal Antibodies (Mabs), by Region/Country, 2023-2035 (USD Million)
  • Table 22 Global Digital Biomanufacturing Market for Recombinant Hormones/Proteins, by Region/Country, 2023-2035 (USD Million)
  • Table 23 Global Digital Biomanufacturing Market for Vaccines, by Region/Country, 2023-2035 (USD Million)
  • Table 24 Global Digital Biomanufacturing Market for Cellular-Based Biologics, by Region/Country, 2023-2035 (USD Million)
  • Table 25 Global Digital Biomanufacturing Market for Gene-Based Biologics, by Region/Country, 2023-2035 (USD Million)
  • Table 26 Global Digital Biomanufacturing Market for Biosimilars, by Region/Country, 2023-2035 (USD Million)
  • Table 27 Global Digital Biomanufacturing Market for Industrial Biotech (Enzymes, Bio-Based Chemicals, Food & Feed Ingredients), by Region/Country, 2023-2035 (USD Million)
  • Table 28 Global Digital Biomanufacturing Market for Others (Blood Products, Peptides, Oligonucleotides), by Region/Country, 2023-2035 (USD Million)
  • Table 29 Global Digital Biomanufacturing Market, by End-User, 2023-2035 (USD Million)
  • Table 30 Global Digital Biomanufacturing Market for Biopharmaceutical Companies, by Region/Country, 2023-2035 (USD Million)
  • Table 31 Global Digital Biomanufacturing Market for Academic and Research Institutes, by Region/Country, 2023-2035 (USD Million)
  • Table 32 Global Digital Biomanufacturing Market for CDMOs & CROs, by Region/Country, 2023-2035 (USD Million)
  • Table 33 Global Digital Biomanufacturing Market for Food & Industrial Biotech Companies, by Region/Country, 2023-2035 (USD Million)
  • Table 34 Global Digital Biomanufacturing Market for Others (Government Labs, Consortia, and Non-Profit Organizations), by Region/Country, 2023-2035 (USD Million)
  • Table 35 North America: Digital Biomanufacturing Market, by Country, 2023-2035 (USD Million)
  • Table 36 North America: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 37 North America: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 38 North America: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 39 North America: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 40 North America: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 41 North America: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 42 U.S.: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 43 U.S.: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 44 U.S.: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 45 U.S.: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 46 U.S.: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 47 U.S.: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 48 Canada: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 49 Canada: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 50 Canada: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 51 Canada: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 52 Canada: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 53 Canada: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 54 Europe: Digital Biomanufacturing Market, by Country/Region, 2023-2035 (USD Million)
  • Table 55 Europe: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 56 Europe: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 57 Europe: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 58 Europe: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 59 Europe: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 60 Europe: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 61 Germany: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 62 Germany: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 63 Germany: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 64 Germany: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 65 Germany: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 66 Germany: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 67 France: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 68 France: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 69 France: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 70 France: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 71 France: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 72 France: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 73 U.K.: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 74 U.K.: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 75 U.K.: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 76 U.K.: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 77 U.K.: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 78 U.K.: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 79 Italy: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 80 Italy: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 81 Italy: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 82 Italy: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 83 Italy: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 84 Italy: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 85 Spain: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 86 Spain: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 87 Spain: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 88 Spain: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 89 Spain: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 90 Spain: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 91 Switzerland: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 92 Switzerland: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 93 Switzerland: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 94 Switzerland: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 95 Switzerland: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 96 Switzerland: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 97 Denmark: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 98 Denmark: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 99 Denmark: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 100 Denmark: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 101 Denmark: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 102 Denmark: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 103 Ireland: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 104 Ireland: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 105 Ireland: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 106 Ireland: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 107 Ireland: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 108 Ireland: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 109 Belgium: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 110 Belgium: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 111 Belgium: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 112 Belgium: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 113 Belgium: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 114 Belgium: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 115 Rest of Europe: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 116 Rest of Europe: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 117 Rest of Europe: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 118 Rest of Europe: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 119 Rest of Europe: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 120 Rest of Europe: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 121 Asia-Pacific: Digital Biomanufacturing Market, by Country/Region, 2023-2035 (USD Million)
  • Table 122 Asia-Pacific: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 123 Asia-Pacific: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 124 Asia-Pacific: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 125 Asia-Pacific: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 126 Asia-Pacific: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 127 Asia-Pacific: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 128 Japan: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 129 Japan: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 130 Japan: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 131 Japan: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 132 Japan: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 133 Japan: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 134 China: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 135 China: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 136 China: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 137 China: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 138 China: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 139 China: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 140 India: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 141 India: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 142 India: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 143 India: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 144 India: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 145 India: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 146 South Korea: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 147 South Korea: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 148 South Korea: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 149 South Korea: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 150 South Korea: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 151 South Korea: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 152 Australia: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 153 Australia: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 154 Australia: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 155 Australia: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 156 Australia: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 157 Australia: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 158 Rest of Asia Pacific: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 159 Rest of Asia Pacific: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 160 Rest of Asia Pacific: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 161 Rest of Asia Pacific: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 162 Rest of Asia Pacific: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 163 Rest of Asia Pacific: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 164 Latin America: Digital Biomanufacturing Market, by Country/Region, 2023-2035 (USD Million)
  • Table 165 Latin America: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 166 Latin America: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 167 Latin America: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 168 Latin America: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 169 Latin America: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 170 Latin America: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 171 Brazil: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 172 Brazil: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 173 Brazil: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 174 Brazil: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 175 Brazil: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 176 Brazil: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 177 Mexico: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 178 Mexico: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 179 Mexico: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 180 Mexico: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 181 Mexico: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 182 Mexico: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 183 Rest of Latin America: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 184 Rest of Latin America: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 185 Rest of Latin America: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 186 Rest of Latin America: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 187 Rest of Latin America: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 188 Rest of Latin America: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 189 Middle East & Africa: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 190 Middle East & Africa: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 191 Middle East & Africa: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 192 Middle East & Africa: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 193 Middle East & Africa: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 194 Middle East & Africa: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 195 Number of Recent Developments, by Company, 2022-2025
  • Table 196 Key Strategic Developments, by Company, 2022-2025

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 In 2025, the Software Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 8 In 2025, the Process Optimization & Analytics Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 9 In 2025, the Upstream Bioprocessing Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 10 In 2025, the Monoclonal Antibodies Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 11 In 2025, the Biopharmaceutical Companies Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 12 Digital Biomanufacturing Market, by Region, 2025 Vs. 2032
  • Figure 13 Factors Affecting Market Growth
  • Figure 14 Global Digital Biomanufacturing Market, by Offering, 2025 Vs. 2035 (USD Million)
  • Figure 15 Global Digital Biomanufacturing Market, by Functionality, 2025 Vs. 2035 (USD Million)
  • Figure 16 Global Digital Biomanufacturing Market, by Bioprocess, 2025 Vs. 2035 (USD Million)
  • Figure 17 Global Digital Biomanufacturing Market, by Application, 2025 Vs. 2035 (USD Million)
  • Figure 18 Global Digital Biomanufacturing Market, by End-User, 2025 Vs. 2035 (USD Million)
  • Figure 19 Global Digital Biomanufacturing Market, by Region, 2025 Vs. 2035 (USD Million)
  • Figure 20 North America: Digital Biomanufacturing Market Snapshot
  • Figure 21 Europe: Digital Biomanufacturing Market Snapshot
  • Figure 22 Asia-Pacific: Digital Biomanufacturing Market Snapshot
  • Figure 23 Latin America: Digital Biomanufacturing Market Snapshot
  • Figure 24 Middle East & Africa: Digital Biomanufacturing Market Snapshot
  • Figure 25 Key Growth Strategies Adopted by Leading Players, 2022-2025
  • Figure 26 Digital Biomanufacturing Market: Competitive Benchmarking, by Region
  • Figure 27 Competitive Dashboard: Digital Biomanufacturing Market
  • Figure 28 Digital Biomanufacturing Market Position Analysis, 2024
  • Figure 29 SWOT Analysis - GE Healthcare Technologies, Inc.
  • Figure 30 SWOT Analysis - Siemens Xcelerator
  • Figure 31 SWOT Analysis - Cytiva
  • Figure 32 SWOT Analysis - ABB Ltd.
  • Figure 33 SWOT Analysis - Sanofi S.A.
  • Figure 34 SWOT Analysis - Emerson Electric Co.
  • Figure 35 SWOT Analysis - Honeywell International, Inc.
  • Figure 36 SWOT Analysis - SAP SE
  • Figure 37 SWOT Analysis - OVO Biomanufacturing Ltd.
  • Figure 38 SWOT Analysis - Schneider Electric SE
  • Figure 39 SWOT Analysis - Dassault Systemes
  • Figure 40 SWOT Analysis - Oracle Corporation
  • Figure 41 SWOT Analysis - 3M